NewEdge Advisors LLC decreased its holdings in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 36.3% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 9,948 shares of the company’s stock after selling 5,679 shares during the period. NewEdge Advisors LLC’s holdings in Astera Labs were worth $1,090,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. Reflection Asset Management bought a new stake in Astera Labs in the fourth quarter worth $25,000. Smartleaf Asset Management LLC boosted its position in Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after buying an additional 152 shares during the period. Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new position in shares of Astera Labs during the fourth quarter valued at about $33,000. Whipplewood Advisors LLC grew its stake in shares of Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after buying an additional 319 shares during the last quarter. Finally, Assetmark Inc. increased its holdings in shares of Astera Labs by 78.9% in the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock worth $38,000 after buying an additional 101 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.
Insider Transactions at Astera Labs
In other Astera Labs news, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total transaction of $1,092,964.15. Following the completion of the transaction, the director owned 53,961 shares of the company’s stock, valued at approximately $16,826,658.63. This trade represents a 6.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 686 shares of the business’s stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $395.04, for a total transaction of $270,997.44. Following the sale, the director owned 5,550 shares in the company, valued at approximately $2,192,472. This trade represents a 11.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 631,979 shares of company stock valued at $215,479,247 in the last three months. Company insiders own 10.40% of the company’s stock.
Astera Labs Price Performance
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business’s revenue was up 104.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current year.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on the company. Evercore reissued an “outperform” rating and issued a $297.00 target price on shares of Astera Labs in a research note on Tuesday, May 19th. Bank of America raised their price target on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 23rd. JPMorgan Chase & Co. lifted their price target on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Susquehanna boosted their price objective on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. Finally, Zacks Research raised Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $333.00.
Check Out Our Latest Research Report on ALAB
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
- Five stocks we like better than Astera Labs
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
